Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Combining two GLP-1 pathway medications provides no additional benefit and significantly increases the risk of side effects, including severe nausea, vomiting, and hypoglycemia
Trainors own fitness trainer, Bella Maher of Malibu Bodies, posted before-and-after photos of the pop star on Instagram, revealing how hard she worked before introducing a GLP-1 drug
Side Effects Nausea Diarrhea Vomiting Constipation Abdominal pain Headache Fatigue Dyspepsia (indigestion) Dizziness Hypoglycemia (low blood sugar, especially when used with other diabetes medications) Gallbladder disease Pancreatitis (inflammation of the pancreas) Increased heart rate Indications Chronic weight management in adults with a body mass index (BMI) of 30 kg/m or greater (obesity) Chronic weight management in adults with a BMI of 27 kg/m or greater (overweight) with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia Adjunct to a reduced-calorie diet and increased physical activity Contraindications Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Hypersensitivity to semaglutide or any of its components Severe gastrointestinal disease (e.g., gastroparesis) Pregnancy and breastfeeding (use with caution) Price Comparison in Different Countries Top 5 Global Brands Wegovy (Novo Nordisk) Ozempic (Novo Nordisk, used primarily for type 2 diabetes) Rybelsus (Novo Nordisk, oral semaglutide for type 2 diabetes) Saxenda (Novo Nordisk, liraglutide for weight management) Trulicity (Eli Lilly, dulaglutide for type 2 diabetes) One of the following licensed pharmacy from the nearest location will deliver Wegovy (semaglutide) injection 2.4 mg
The distinction affects insurance coverage and prescribing criteria but not the medication itself
Serious Warnings Some GLP-1 receptor agonist medications (including semaglutide and tirzepatide products) carry a boxed warning -the FDA's most serious warning-regarding thyroid C-cell tumors
